| Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamide | |
| Kong, Xiufang; Zhang, Xiaojie; Lv, Peng; Cui, Xiaomeng; Ma, Lili; Chen, Huiyong; Liu, Hao; Lin, Jiang; Jiang, Lindi | |
| 刊名 | INTERNATIONAL JOURNAL OF CARDIOLOGY
 |
| 2018 | |
| 卷号 | 266 |
| 关键词 | Takayasu arteritis Tocilizumab Cyclophosphamide IL-6 MMP-9 Treatment effect |
| ISSN号 | 0167-5273 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3600297 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Kong, Xiufang,Zhang, Xiaojie,Lv, Peng,et al. Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamide[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY,2018,266. |
| APA | Kong, Xiufang.,Zhang, Xiaojie.,Lv, Peng.,Cui, Xiaomeng.,Ma, Lili.,...&Jiang, Lindi.(2018).Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamide.INTERNATIONAL JOURNAL OF CARDIOLOGY,266. |
| MLA | Kong, Xiufang,et al."Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamide".INTERNATIONAL JOURNAL OF CARDIOLOGY 266(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论